MedTrace Logo

Mitochondrial Biomarkers in Huntington's Disease

NCT04515550 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 27

Last updated 2022-04-12

No results posted yet for this study

Summary

The objective of this study is to discover a panel of mitochondrial metabolomics biomarkers for Huntington's disease.

Conditions

  • Huntington Disease

Interventions

DIAGNOSTIC_TEST

lumbar puncture

Some participants will have an optional lumbar puncture

Sponsors & Collaborators

  • Case Western Reserve University

    collaborator OTHER

  • National Institute of Neurological Disorders and Stroke (NINDS)

    collaborator NIH

  • The Cleveland Clinic

    collaborator OTHER

  • University Hospitals Cleveland Medical Center

    lead OTHER

Principal Investigators

  • Xin Qi, PhD · Case Western Reserve University

Eligibility

Min Age
20 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-04
Primary Completion
2022-02-28
Completion
2022-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04515550 on ClinicalTrials.gov